Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “VTE Prophylaxis”

125 trials

Showing 20 of 125 results

Large-scale testing (Phase 3)Study completedNCT00329238
What this trial is testing

Secondary Prevention of Venous Thrombo Embolism (VTE).

Who this might be right for
Thromboembolism
Boehringer Ingelheim 2,867
Large-scale testing (Phase 3)Looking for participantsNCT05920343
What this trial is testing

VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy

Who this might be right for
Venous ThromboembolismUrologic Cancer
Ottawa Hospital Research Institute 120
Testing effectiveness (Phase 2)Study completedNCT02048865
What this trial is testing

Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients

Who this might be right for
Venous ThromboembolismCancer
Ottawa Hospital Research Institute 575
Not applicableStudy completedNCT04341272
What this trial is testing

Intermittent Pneumatic Compression of the Upper Extremity for Post-Operative VTE Prophylaxis

Who this might be right for
Venous Thromboses
Baltimore VA Medical Center 106
Post-approval studies (Phase 4)UnknownNCT00699465
What this trial is testing

Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage

Who this might be right for
Intracerebral Hemorrhage
University of Oulu 320
Large-scale testing (Phase 3)Study completedNCT00332020
What this trial is testing

Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

Who this might be right for
PreventionVenous Thromboembolism
Bayer 2,457
Not applicableStudy completedNCT02546817
What this trial is testing

Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS

Who this might be right for
Venous Thromboembolism
Bristol-Myers Squibb 29
Large-scale testing (Phase 3)Study completedNCT00694382
What this trial is testing

Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy

Who this might be right for
Venous ThromboembolismCancer
Sanofi 3,212
Not applicableUnknownNCT03593291
What this trial is testing

LMWH-VTE Prophylaxis for Survivors of Acute Ischemic Stroke- Assessment of Standard Dosing Regimen

Who this might be right for
Stroke
Loewenstein Hospital 100
Not applicableLooking for participantsNCT03728166
What this trial is testing

Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)

Who this might be right for
Venous Thromboembolism
Brigham and Women's Hospital 400
Post-approval studies (Phase 4)Study completedNCT00077753
What this trial is testing

EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization

Who this might be right for
Venous Thromboembolism
Sanofi 4,726
Large-scale testing (Phase 3)Study completedNCT00361894
What this trial is testing

Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement.

Who this might be right for
PreventionVenous Thromboembolism
Bayer 2,531
Testing effectiveness (Phase 2)Study completedNCT00839826
What this trial is testing

ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial

Who this might be right for
ThromboembolismPrevention
Bayer 641
Not applicableStudy completedNCT03243708
What this trial is testing

Title: Randomized Trial of an EHR Embedded Risk Calculator vs. Standard VTE Prophylaxis for Medical Patients

Who this might be right for
Venous Thromboembolism
The Cleveland Clinic 90,537
Not applicableEnded earlyNCT03465735
What this trial is testing

Vascular Boot Warming Program After Acute Deep Vein Thrombosis (DVT) ± Pulmonary Embolism (PE)

Who this might be right for
Acute DVT of Lower Extremity
Mayo Clinic 15
Large-scale testing (Phase 3)Not Yet RecruitingNCT07493304
What this trial is testing

Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

Who this might be right for
Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals 1,600
Not applicableStudy completedNCT00831714
What this trial is testing

Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty

Who this might be right for
Venous Thromboembolism
Bayer 19,076
Not applicableStudy completedNCT03367364
What this trial is testing

Patient Education Bundle vs. Nurses Feedback and Coaching to Prevent Missed Doses of VTE Prophylaxis

Who this might be right for
Venous Thrombosis (Disorder)
Johns Hopkins University 9,657
Not applicableStudy completedNCT02402881
What this trial is testing

Education Bundle to Decrease Patient Refusal of VTE Prophylaxis

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism
Johns Hopkins University 19,652
Large-scale testing (Phase 3)Study completedNCT01583218
What this trial is testing

Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)

Who this might be right for
Venous Thromboembolism (VTE)
Portola Pharmaceuticals 7,513
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation